|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.10 USD | +0.38% |
|
+1.31% | +42.50% |
| 04:43pm | HCA Healthcare's Peak Valuation Limits Upside After Years of Outperformance, Morgan Stanley Says | MT |
| 04:31pm | Hershey Poised for Multi-Year Earnings Recovery, Morgan Stanley Says | MT |
Projected Income Statement: Morgan Stanley
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 48,198 | 59,755 | 53,668 | 54,143 | 61,761 | 70,230 | 73,987 | 77,914 |
| Change | - | 23.98% | -10.19% | 0.89% | 14.07% | 13.71% | 5.35% | 5.31% |
| EBITDA | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| EBIT 1 | 14,418 | 19,672 | 14,369 | 12,345 | 17,860 | 21,046 | 21,442 | 23,038 |
| Change | - | 36.44% | -26.96% | -14.09% | 44.67% | 17.84% | 1.88% | 7.45% |
| Interest Paid | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | 14,418 | 19,668 | 14,089 | 11,813 | 17,596 | 21,402 | 22,476 | 24,147 |
| Change | - | 36.41% | -28.37% | -16.15% | 48.95% | 21.63% | 5.02% | 7.44% |
| Net income 1 | 10,500 | 14,566 | 10,540 | 8,530 | 12,800 | 15,813 | 16,664 | 17,896 |
| Change | - | 38.72% | -27.64% | -19.07% | 50.06% | 23.54% | 5.38% | 7.39% |
| Announcement Date | 20/01/21 | 19/01/22 | 17/01/23 | 16/01/24 | 16/01/25 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: Morgan Stanley
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 185,606 | 189,930 | 196,302 | 187,155 | 205,035 | 228,557 | 228,557 | 228,557 |
| Change | - | 2.33% | 3.35% | -4.66% | 9.55% | 11.47% | 0% | 0% |
| Announcement Date | 20/01/21 | 19/01/22 | 17/01/23 | 16/01/24 | 16/01/25 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: Morgan Stanley
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| CAPEX 1 | 1,826 | 1,444 | 2,308 | 3,078 | 3,412 | 3,462 |
| Change | - | -20.92% | 59.83% | 33.36% | 10.85% | 1.47% |
| Free Cash Flow (FCF) 1 | - | - | - | - | - | - |
| Change | - | - | - | - | - | - |
| Announcement Date | 27/02/20 | 26/02/21 | 24/02/22 | 24/02/23 | 22/02/24 | 21/02/25 |
1USD in Million
Estimates
Forecast Financial Ratios: Morgan Stanley
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | - | - | - | - | - | - | - | - |
| EBIT Margin (%) | 29.91% | 32.92% | 26.77% | 22.8% | 28.92% | 29.97% | 28.98% | 29.57% |
| EBT Margin (%) | 29.91% | 32.91% | 26.25% | 21.82% | 28.49% | 30.47% | 30.38% | 30.99% |
| Net margin (%) | 21.79% | 24.38% | 19.64% | 15.75% | 20.73% | 22.52% | 22.52% | 22.97% |
| FCF margin (%) | - | - | - | -68.24% | - | - | - | - |
| FCF / Net Income (%) | - | - | - | -433.15% | - | - | - | - |
Profitability | ||||||||
| ROA | 1.04% | 1.3% | 0.92% | 0.72% | 1.06% | 1.23% | 1.2% | 1.24% |
| ROE | 13.1% | 15% | 11.2% | 9.4% | 14% | 16.17% | 16.25% | 16.79% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | -5.07x | - | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | - | - | - | 6.3% | - | - | - | - |
| CAPEX / EBITDA (%) | - | - | - | - | - | - | - | - |
| CAPEX / FCF (%) | - | - | - | -9.23% | - | - | - | - |
Items per share | ||||||||
| Cash flow per share 1 | -15.54 | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | 1.4 | 2.45 | 3.025 | 3.25 | 3.625 | 3.862 | 4.21 | 4.686 |
| Change | - | 75% | 23.47% | 7.44% | 11.54% | 6.55% | 9% | 11.31% |
| Book Value Per Share 1 | 51.13 | 55.12 | 54.55 | 55.5 | 58.98 | 63.4 | 67.56 | 72.29 |
| Change | - | 7.8% | -1.03% | 1.74% | 6.27% | 7.49% | 6.56% | 7% |
| EPS 1 | 6.46 | 8.03 | 6.15 | 5.18 | 7.95 | 9.91 | 10.58 | 11.77 |
| Change | - | 24.3% | -23.41% | -15.77% | 53.47% | 24.65% | 6.72% | 11.29% |
| Nbr of stocks (in thousands) | 1,809,198 | 1,794,412 | 1,690,109 | 1,641,312 | 1,611,036 | 1,589,309 | 1,589,309 | 1,589,309 |
| Announcement Date | 20/01/21 | 19/01/22 | 17/01/23 | 16/01/24 | 16/01/25 | - | - | - |
1USD
Estimates
| 2025 * | 2026 * | |
|---|---|---|
| P/E ratio | 18x | 16.9x |
| PBR | 2.81x | 2.64x |
| EV / Sales | 7.29x | 6.92x |
| Yield | 2.16% | 2.36% |
More valuation ratios
* Estimated data
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
178.41USD
Average target price
170.19USD
Spread / Average Target
-4.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MS Stock
- Financials Morgan Stanley
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















